Suppr超能文献

藤黄果(羟基柠檬酸)对内脏脂肪堆积的影响:一项双盲、随机、安慰剂对照试验。

Effects of garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial.

作者信息

Hayamizu Kohsuke, Ishii Yuri, Kaneko Izuru, Shen Manzhen, Okuhara Yasuhide, Shigematsu Norihiro, Tomi Hironori, Furuse Mitsuhiro, Yoshino Gen, Shimasaki Hiroyuki

机构信息

Central Research Laboratory, FANCL Corp., Kanagawa, Japan, ; Laboratory of Advanced Animal and Marine Bioresources, Faculty of Agriculture, Kyushu University, Fukuoka, Japan.

Central Research Laboratory, FANCL Corp., Kanagawa, Japan.

出版信息

Curr Ther Res Clin Exp. 2003 Sep;64(8):551-67. doi: 10.1016/j.curtheres.2003.08.006.

Abstract

BACKGROUND

(-)-Hydroxycitric acid (HCA) is an active ingredient extracted from the rind of the Indian fruit Garcinia cambogia. It inhibits adenosine triphosphate citrate lyase and has been used in the treatment of obesity.

OBJECTIVE

The primary end point of this study was the effects of 12 weeks of G cambogia extract administration on visceral fat accumulation. The secondary end points were body indices (including height, body weight, body mass index [BMI], waist and hip circumference, and waist-hip ratio) and laboratory values (including total cholesterol, triacylglycerol, and free fatty acid).

METHODS

This study was performed according to a double-blind, randomized, placebo-controlled, parallel-group design. Subjects aged 20 to 65 years with a visceral fat area >90 cm(2) were enrolled. Subjects were randomly assigned to receive treatment for 12 weeks with G cambogia (containing 1000 mg of HCA per day) or placebo. At the end of the treatment period, both groups were administered placebo for 4 weeks to assess any rebound effect. Each subject underwent a computed tomography scan at the umbilical level at -2, 0, 12, and 16 weeks.

RESULTS

Forty-four subjects were randomized at baseline, and 39 completed the study (G cambogia group, n = 18; placebo group, n = 21). At 16 weeks, the G cambogia group had significantly reduced visceral, subcutaneous, and total fat areas compared with the placebo group (all indices P<0.001). No severe adverse effect was observed at any time in the test period. There were no significant differences in BMI or body weight at week 12, but there were slight numeric decreases in body weight and BMI in men. There were no signs of a rebound effect from week 12 to week 16.

CONCLUSION

G cambogia reduced abdominal fat accumulation in subjects, regardless of sex, who had the visceral fat accumulation type of obesity. No rebound effect was observed. It is therefore expected that G cambogia may be useful for the prevention and reduction of accumulation of visceral fat.

摘要

背景

(-)-羟基柠檬酸(HCA)是从印度藤黄果的果皮中提取的一种活性成分。它能抑制三磷酸腺苷柠檬酸裂解酶,已被用于治疗肥胖症。

目的

本研究的主要终点是给予藤黄果提取物12周对内脏脂肪堆积的影响。次要终点是身体指标(包括身高、体重、体重指数[BMI]、腰围和臀围以及腰臀比)和实验室指标(包括总胆固醇、三酰甘油和游离脂肪酸)。

方法

本研究按照双盲、随机、安慰剂对照、平行组设计进行。纳入年龄在20至65岁之间且内脏脂肪面积>90 cm²的受试者。受试者被随机分配接受藤黄果(每天含1000 mg HCA)或安慰剂治疗12周。在治疗期结束时,两组均给予安慰剂4周以评估任何反弹效应。每位受试者在第-2、0、12和16周时在脐水平进行计算机断层扫描。

结果

44名受试者在基线时被随机分组,39名完成了研究(藤黄果组,n = 18;安慰剂组,n = 21)。在第16周时,与安慰剂组相比,藤黄果组的内脏、皮下和总脂肪面积显著减少(所有指标P<0.001)。在试验期间的任何时候均未观察到严重不良反应。在第12周时,BMI或体重无显著差异,但男性的体重和BMI有轻微的数值下降。从第12周到第16周没有反弹效应的迹象。

结论

藤黄果可减少内脏脂肪堆积型肥胖受试者(无论性别)的腹部脂肪堆积。未观察到反弹效应。因此,预计藤黄果可能有助于预防和减少内脏脂肪堆积。

相似文献

1
藤黄果(羟基柠檬酸)对内脏脂肪堆积的影响:一项双盲、随机、安慰剂对照试验。
Curr Ther Res Clin Exp. 2003 Sep;64(8):551-67. doi: 10.1016/j.curtheres.2003.08.006.
2
藤黄果(羟基柠檬酸)作为一种潜在的抗肥胖剂:一项随机对照试验。
JAMA. 1998 Nov 11;280(18):1596-600. doi: 10.1001/jama.280.18.1596.
3
藤黄果的全面科学综述。
Fitoterapia. 2015 Apr;102:134-48. doi: 10.1016/j.fitote.2015.02.012. Epub 2015 Feb 27.
4
藤黄果加魔芋治疗肥胖症的药物治疗效果评估。
Phytother Res. 2008 Sep;22(9):1135-40. doi: 10.1002/ptr.2323.
5
藤黄果提取物对超重受试者血清性激素的影响。
Fitoterapia. 2008 Jun;79(4):255-61. doi: 10.1016/j.fitote.2007.12.003. Epub 2008 Feb 9.
7
藤黄果补充剂对肥胖指数的影响:系统评价和剂量反应荟萃分析。
Complement Ther Med. 2020 Aug;52:102451. doi: 10.1016/j.ctim.2020.102451. Epub 2020 May 23.
8
藤黄果对肥胖女性的降脂作用。
Phytother Res. 2014 Jun;28(6):887-91. doi: 10.1002/ptr.5076. Epub 2013 Oct 17.
10
评估羟基柠檬酸或藤黄果提取物在人体中的安全性和有效性。
Crit Rev Food Sci Nutr. 2012;52(7):585-94. doi: 10.1080/10408398.2010.500551.

引用本文的文献

1
Q180与(CKDB - 322)对高脂饮食诱导的肥胖小鼠的协同抗肥胖作用
Int J Mol Sci. 2025 Aug 19;26(16):7991. doi: 10.3390/ijms26167991.
2
用于递送抗肥胖天然化合物的脂质基纳米载体:靶向递送与精准治疗的进展
J Nanobiotechnology. 2025 May 7;23(1):336. doi: 10.1186/s12951-025-03412-z.
3
栽培和野生热带水果物种的DNA条形码鉴定
3 Biotech. 2024 Jan;14(1):7. doi: 10.1007/s13205-023-03848-w. Epub 2023 Dec 7.
4
米勒果实提取物通过激活AMPK信号通路对3T3-L1脂肪细胞发挥抗肥胖作用。
Nutr Res Pract. 2023 Dec;17(6):1043-1055. doi: 10.4162/nrp.2023.17.6.1043. Epub 2023 Aug 21.
5
体重减轻还是肝脏受损:一例因服用藤黄果补充剂继发暴发性肝衰竭的病例报告
Cureus. 2023 Jul 12;15(7):e41778. doi: 10.7759/cureus.41778. eCollection 2023 Jul.
7
水提取物可减轻高脂饮食喂养小鼠的胰岛素抵抗和肝脏脂质积累。
Food Nutr Res. 2023 Mar 14;67. doi: 10.29219/fnr.v67.8977. eCollection 2023.
8
羟基柠檬酸抗肥胖作用的临床与计算研究
RSC Adv. 2019 Jun 12;9(32):18578-18588. doi: 10.1039/c9ra01345h. eCollection 2019 Jun 10.
9
一种用于定量测定啮齿动物血浆和胎儿中提取物关键成分羟基柠檬酸的分析方法的开发与验证。
Anal Lett. 2022;55(9):1382-1397. doi: 10.1080/00032719.2021.2005618. Epub 2021 Dec 11.
10
营养与临床试验中的热量限制模拟物
Front Nutr. 2021 Sep 6;8:717343. doi: 10.3389/fnut.2021.717343. eCollection 2021.

本文引用的文献

1
饮食和身体活动对肥胖及体脂分布的影响:对预防心血管疾病的意义
Nutr Res Rev. 1993 Jan;6(1):137-59. doi: 10.1079/NRR19930010.
2
藤黄果(羟基柠檬酸)作为一种潜在的抗肥胖剂:一项随机对照试验。
JAMA. 1998 Nov 11;280(18):1596-600. doi: 10.1001/jama.280.18.1596.
4
超重、体重过轻与死亡率。对48287名男性和女性的前瞻性研究。
Arch Intern Med. 1996 May 13;156(9):958-63. doi: 10.1001/archinte.156.9.958.
5
内脏脂肪型肥胖的病理生理学与发病机制
Obes Res. 1995 Sep;3 Suppl 2:187S-194S. doi: 10.1002/j.1550-8528.1995.tb00462.x.
6
内脏脂肪堆积对非肥胖男性冠状动脉疾病发生的影响
Atherosclerosis. 1994 Jun;107(2):239-46. doi: 10.1016/0021-9150(94)90025-6.
7
中度肥胖对健康的影响。
Int J Obes. 1981;5(2):97-116.
8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验